Ann: CEO Presentation , page-8

Good presentation but still a while in it don't know about your $100-$200M in 12 months Massey ?

'14/'15/'16 and again represented in the presentation.

Look at the comparison companies they all have heavy cash backing, advanced / multiple candidates from Ph I through to III &/or big pharma partners to go with the cash.

ECQ looking at PhaseI 2H 2014 or 2015 depending on regulatory approval.

Good story but I still think not as fast as some are anticipating.

But there can always be black swans lurking so neatly tucked away :-)